Autoimmunity Digital Spatial Profiling Neuroscience Oncology
Readers’ Favorite Webinars: A Year in Review
NanoString webinars allow you to sit back, relax and listen to a leader in the field talk about his/her research and/or answer your questions. They have always been a crowd-pleaser,…
Autoimmunity Oncology
Top 5 Q&A Blog Posts from 2019
Our readers heartily consumed our Q&A blog posts, a series of interviews with scientists from all over the globe who shared with us and our readers the hypotheses behind their…
Autoimmunity Events Neuroscience Oncology Publication Watch
Top 5 Blog Posts of 2019
Last year marked remarkable progress for our customers, with hundreds of scientists making exceptional strides in their fields thanks to NanoString® technologies. 2019 saw the commercial launch of the GeoMx™…
Autoimmunity Events Oncology
Cancer Immunotherapy at SITC 2019: The Good, the Bad and the Solution
The Society for Immunotherapy of Cancer’s 34th Annual Meeting hosted an array of multidisciplinary and interactive sessions focused on basic and applied cancer immunotherapy. The introduction of Immune Checkpoint Inhibitors…
Autoimmunity
How to Resolve the Complexity of Autoimmune Diseases
What are Autoimmune Diseases? Autoimmune diseases are chronic inflammatory conditions, life-long debilitating illnesses with increased mortality, and high healthcare costs for therapy and care. They are systemic conditions characterized by…
Autoimmunity
Q&A with Dr. Maureen McGargill, PhD: The Immune System’s Fine Line Between Health and Harm
Dr. McGargill earned her PhD at the University of Minnesota in Dr. Kristin Hogquist’s lab. There she studied T cell development, focusing on how autoreactive T cells are deleted during…
Autoimmunity
“In sickness and in health”: how individual immune response variability in health may influence how we respond to illness and therapy.
Thomas Fuller once said: “Health is not valued till sickness comes.” Well, that may not be true anymore. It turns out that the key to successful disease management strategies may…
Autoimmunity
Identifying Signaling Pathways and Biomarkers in Autoimmune Diseases
As efforts in developing targeted therapies for autoimmune disease are rapidly advancing in basic research, scientists aim to validate immunology-relevant signaling pathways and uncover new intracellular molecules as potential drug…
Autoimmunity
Q&A with Dr. Oliver Brain: Unintended Consequences Create a Unique Opportunity to Study Inflammatory Bowel Disease.
Oliver Brain, MRCP, PhD, is a principal investigator at the University of Oxford, Nuffield Department of Clinical Medicine, and a recent winner of an nCounter® Autoimmune Profiling Panel through a…
Autoimmunity
Q&A with Dr. Salla Keskitalo: Challenges and Opportunities in Studying Rare and Ultra-rare Autoimmune Diseases
Dr. Salla Keskitalo is a Senior Research Scientist at the University of Helsinki and a recent winner of NanoString’s Autoimmunity Grant Program. She made time to speak with us about…
Autoimmunity Q&A
Q&A with Darragh Duffy, Ph.D. – Understanding the Healthy Human Immune Response with the LabEx Milieu Interieur Project
Darragh Duffy, Ph.D., is the Scientific Manager of the LabEx Milieu Interieur project at the Institut Pasteur in Paris, France. This ambitious program started in 2011 with the mission to understand…
Autoimmunity
The Chronic(als) of Autoimmunity
Political climate aside, life in Britain in the 1930’s and 1940’s was harsh and infectious disease (particularly tuberculosis) was one of the most urgent health problems; such infections favored the…